Seoul, South Korea
June 23, 2026
5A
Type: Global Innovation Hub Session
Seoul: Asia’s Strategic Bio & Clinical Innovation Hub
Seoul is an emerging bio hub where clinical development, R&D, capital, and advanced manufacturing converge.
The city hosts a dense ecosystem of over 1,200 biotech and life sciences companies, leading universities, and world-class hospitals, enabling strong collaboration and open innovation.
With near-universal healthcare coverage, Seoul provides access to large-scale real-world data, supporting fast and efficient clinical research.
Korea consistently ranks among the top countries globally in clinical trial activity, positioning Seoul as a leading clinical hub in Asia.
Together, this integrated ecosystem makes Seoul a strategic gateway for biotech innovation and expansion across the Asia-Pacific region.
Company HQ City:
Seoul
Company HQ Country:
Korea, Republic of
Primary Speaker
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}